Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2004

01-04-2004 | Case Report

Tuberculosis in hematopoletk stem cell transplant recipients in Korea

Authors: Jeeyun Lee, Mark H. Lee, Won Seog Kim, Kihyun Kim, Se Hoon Park, Se-Hoon Lee, Kyung-Bun Lee, Jinny Park, Joon Oh Park, Chul Won Jung, Young-Hyuck Im, Won Ki Kang, Keunchil Park

Published in: International Journal of Hematology | Issue 2/2004

Login to get access
Metadata
Title
Tuberculosis in hematopoletk stem cell transplant recipients in Korea
Authors
Jeeyun Lee
Mark H. Lee
Won Seog Kim
Kihyun Kim
Se Hoon Park
Se-Hoon Lee
Kyung-Bun Lee
Jinny Park
Joon Oh Park
Chul Won Jung
Young-Hyuck Im
Won Ki Kang
Keunchil Park
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
International Journal of Hematology / Issue 2/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.A10219

Other articles of this Issue 2/2004

International Journal of Hematology 2/2004 Go to the issue

Case Report

Quantitative assessment of disease involvement by follicular lymphoma using real-time polymerase chain reaction measurement of t(14;18)-carrying cells

OriginalPaper

Membranous nephropathy after allogeneic stem cell transplantation: meport of 2 cases

Case Report

Successful treatment of µ-heavy chain disease with fludarabine monophosphate: A case report

Letter

Paralytic ileus occurring during treatment with all-trans retinoic acid for acute promyelocytic leukemia

OriginalPaper

Progress in the understanding of protease-activated receptors

Case Report

Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits